About Amber Salzman
Amber Salzman is a chief executive officer and director at Epicrispr Biotechnologies.
Experience
This experience comes from Amber Salzman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Amber Salzman in the role, so the role may have started earlier or lasted longer.
Epicrispr Biotechnologies, Inc. Current
CEO (2021 – Present)
Director
2021 – Present · South San Francisco, CA
Develops gene-regulating therapies for people with serious diseases.
AB
Aviado Bio Current
Board Member
2021 – Present
OD
Osler Diagnostics Current
Board Member
2020 – Present
BO
Biotechnology Innovation Organization Current
Board Member
2020 – Present
OI
Ohana Biosciences, Inc.
President & CEO
2018 – 2021
AT
Akcea Therapeutics
Board Member
2020
AI
Adverum Biotechnologies, Inc.
CEO & President
2016 – 2018
AT
Annapurna Therapeutics
President & CEO
2012 – 2016
CA
Cardiokine
President & CEO
2009 – 2011
VI
Venuvics Pharmaceuticals Inc.
President
2008 – 2009
GL
GlaxoSmithKline
SVP Medicine Development Operations
2000 – 2008
SB
Smithkline Beecham
SVP
1983 – 2000
Key Colleagues at Startups
The people Amber Salzman works with at each company, as listed on that company's latest Form D.
Epicrispr Biotechnologies, Inc. · Form D, Aug 26, 2026
LQ
Lei Qi
Scientific Founder and director
EC
Eric Crombez
Director
AL
Anran Li
Director
HZ
Haorui Zhang
Executive officer and director
JK
Jennifer King
Director
AL
Andrew Lam
Director